COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,440 Articles (22,835 medRxiv, 8,605 bioRxiv)

Most recent first Previous |  Page 511: Articles 5101-5110  | Next

Seroprevalence of IgG Antibody against SARS-CoV-2 Nucleocapsid protein and Associated Risk Factors
Chowdhury, Y. F., Hossen, F., Islam, S. M. R., Hossain, M. S., Mahtab-Ul-Islam, K., Chowdhury, S. I., Hasan, M. R., Tasnim, N., Shaikh, M. A. A., Karim, M. R.
10.1101/2023.02.09.527802 — Posted: 2023-02-09
Rapid assembly of SARS-CoV-2 genomes reveals attenuation of the Omicron BA.1 variant through NSP6
Taha, T. Y., Chen, I. P., Hayashi, J. M., Tabata, T., Walcott, K., Kimmerly, G. R., Syed, A. M., Ciling, A., Suryawanshi, R. K., Martin, H. S., Bach, B. H., Tsou, C.-L., Montano, M., Khalid, M. M., Sreekumar, B. K., Kumar, G. R., Wyman, S., Doudna, J. A., Ott, M.
10.1101/2023.01.31.525914 — Posted: 2023-02-09
Factors Associated with Stroke after COVID-19 Vaccination: A Statewide Analysis
Nahab, F., Bayakly, R., Sexton, M. E., Lemuel-Clarke, M., Henriquez, L., Rangaraju, S., Ido, M.
10.1101/2023.02.05.23285486 — Posted: 2023-02-09
Individual costs and societal benefits of interventions during the COVID-19 pandemic
Traulsen, A., Levin, S. A., Saad-Roy, C. M.
10.1101/2023.02.08.23285651 — Posted: 2023-02-08
Counterintuitive effect of antiviral therapy on influenza A-SARS-CoV-2 coinfection due to viral interference
Cheemarla, N. R., Mihaylova, V. T., Watkins, T. A., Foxman, E. F.
10.1101/2023.02.07.527372 — Posted: 2023-02-08
Quantification of impact of COVID-19 pandemic on cancer screening programmes -a case study from Argentina, Bangladesh, Colombia, Morocco, Sri Lanka and Thailand
Lucas, E., Murillo, R., Arrossi, S., Barcena, M., Chami, Y., Nessa, A., Perera, S., Silva, J. P., Sangrajrang, S., Muwonge, R., Basu, P.
10.1101/2023.02.07.23285574 — Posted: 2023-02-08
Patterns of testing in the extensive Danish national SARS-CoV-2 test set-up
Gram, M. A., Steenhard, N., Cohen, A. S., Vangsted, A.-M., Molbak, K., Jensen, T. G., Hansen, C. H., Ethelberg, S.
10.1101/2023.02.06.23285556 — Posted: 2023-02-08
Autoantigen profiling reveals a shared post-COVID signature in fully recovered and Long COVID patients
Bodansky, A., Wang, C.-Y., Saxena, A., Mitchell, A., Takahashi, S., Anglin, K., Huang, B., Hoh, R., Lu, S., Goldberg, S. A., Romero, J., Tran, B., Kirtikar, R., Grebe, H., So, M., Greenhouse, B., Durstenfeld, M. S., Hsue, P. Y., Hellmuth, J., Kelly, J. D., Martin, J. N., Anderson, M. S., Deeks, S. G., Henrich, T. J., DeRisi, J. L., Peluso, M. J.
10.1101/2023.02.06.23285532 — Posted: 2023-02-08
A Phase 2, Randomized, Double-blind, Placebo-controlled Study of oral RP7214, a DHODH inhibitor, in Patients with Symptomatic Mild SARS-CoV-2 Infection
Nair, A., Barde, P., Routhu, K. V., Vakkalanka, S., RP7214-2101 Study Group Investigator Authors (India)
10.1101/2023.02.08.23285565 — Posted: 2023-02-08
Mental distress among Norwegian adults during the Covid-19 pandemic: predictors of initial response and subsequent trajectories
Lu, L., Hannigan, L. J., Brandlistuen, R. E., Nesvag, R., Trogstad, L., Magnus, P., Unnarsdottir, A. B., Valdimarsdottir, U. A., Andreassen, O. A., Ask, H.
10.1101/2023.02.06.23285436 — Posted: 2023-02-08

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).